Furthermore, the CTC-ALRI score outperformed conventional factors (AFP, tumor size) and established models (BCLC, TNM, ERASL, SSCLIP, Korean), with areas under the curve of 0.725 and 0.729 for one- and two-year recurrence prediction. The gene discussed is AFP; the disease is neoplasm.